118 related articles for article (PubMed ID: 27595400)
21. Comparative effectiveness of primary tumor resection versus chemotherapy in patients with asymptomatic unresectable metastatic colorectal cancer: a retrospective cohort study using the target trial emulation framework.
Wu CC; Su CC; Lee PT; Chen YH; Hsu CW; Su YC
Am J Cancer Res; 2024; 14(5):2172-2186. PubMed ID: 38859829
[TBL] [Abstract][Full Text] [Related]
22. Palliative primary tumor resection provides survival benefits for the patients with metastatic colorectal cancer and low circulating levels of dehydrogenase and carcinoembryonic antigen.
He WZ; Rong YM; Jiang C; Liao FX; Yin CX; Guo GF; Qiu HJ; Zhang B; Xia LP
Chin J Cancer; 2016 Jun; 35(1):58. PubMed ID: 27357402
[TBL] [Abstract][Full Text] [Related]
23. A liquid biopsy signature of circulating extracellular vesicles-derived RNAs predicts response to first line chemotherapy in patients with metastatic colorectal cancer.
Yang Y; Zhang J; Zhang W; Wang Y; Zhai Y; Li Y; Li W; Chang J; Zhao X; Huang M; Geng Q; Yang Y; Gong Z; Yu N; Shen W; Li Q; Huang S; Guo W
Mol Cancer; 2023 Dec; 22(1):199. PubMed ID: 38062470
[TBL] [Abstract][Full Text] [Related]
24. Real-World Clinical Outcomes of Bevacizumab-awwb Biosimilar versus Bevacizumab Reference Product in Patients with Metastatic Colorectal Cancer.
Pham C; Niu F; Delate T; Buchschacher GL; Li Y; Ekinci E; Le K; Hui RL
BioDrugs; 2023 Nov; 37(6):891-899. PubMed ID: 37747629
[TBL] [Abstract][Full Text] [Related]
25. Asymptomatic primary tumour in incurable metastatic colorectal cancer: is there a role for surgical resection prior to systematic therapy or not?
Samalavicius NE; Dulskas A; Baltruskeviciene E; Smailyte G; Skuciene M; Mikelenaite R; Venslovaite R; Aleknavicius E; Samalavicius A; Lunevicius R
Wideochir Inne Tech Maloinwazyjne; 2016; 11(4):274-282. PubMed ID: 28194248
[TBL] [Abstract][Full Text] [Related]
26. Clinical Outcomes of Upfront Primary Tumor Resection in Synchronous Unresectable Metastatic Colorectal Cancer.
Shin JE; An HJ; Shim BY; Kim H; Park HS; Cho HM; Kye BH; Yoo RN; Moon JY; Kim SH; Lee J; Lee HC; Jung JH; Lee KM; Lee JM
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894424
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive molecular analysis to predict the efficacy of chemotherapy containing bevacizumab in patients with metastatic colorectal cancer.
Lim SH; Cho HJ; Kim KM; Lim HY; Kang WK; Lee J; Park YS; Kim HC; Kim ST
Oncol Res; 2023; 31(6):855-866. PubMed ID: 37744267
[TBL] [Abstract][Full Text] [Related]
28. Primary Tumor Resection for Stage IV Colorectal Cancer in the Era of Targeted Chemotherapy.
Shida D; Boku N; Tanabe T; Yoshida T; Tsukamoto S; Takashima A; Kanemitsu Y
J Gastrointest Surg; 2019 Nov; 23(11):2144-2150. PubMed ID: 30484063
[TBL] [Abstract][Full Text] [Related]
29. Left-sided primary tumor is a favorable prognostic factor for metastatic colorectal cancer patients receiving surgery.
Li XF; Tan YN; Zhong CH; Zhu LZ; Fang XF; Li J; Ding KF; Yuan Y
Oncotarget; 2017 Oct; 8(45):79618-79628. PubMed ID: 29108341
[TBL] [Abstract][Full Text] [Related]
30. Symptom burden & quality of life among patients receiving second-line treatment of metastatic colorectal cancer.
Walker MS; Pharm EY; Kerr J; Yim YM; Stepanski EJ; Schwartzberg LS
BMC Res Notes; 2012 Jun; 5():314. PubMed ID: 22716038
[TBL] [Abstract][Full Text] [Related]
31. Upfront primary tumor resection versus upfront systemic therapy for metastatic colorectal cancer: a systematic review and meta-analysis.
Lo SJ; Huang SH; Lai IL; Chern YJ; Hsu YJ; Liao CK; Cheng CC; Tsai WS; Hsieh PS; You JF
Int J Colorectal Dis; 2023 Jul; 38(1):186. PubMed ID: 37405554
[TBL] [Abstract][Full Text] [Related]
32. Triplet chemotherapy with or without bevacizumab as first line treatment for metastatic colorectal cancer: An AGEO multicenter real-world study.
Varnier R; Toullec C; Philonenko S; Dupré A; Artru P; Hafliger E; Drouillard A; Torregrosa C; Pernot S; McLellan P; Lecomte T; Moulin V; Lécaille C; Touchefeu Y; Locher C; Taieb J; Coutzac C
Dig Liver Dis; 2024 Feb; ():. PubMed ID: 38403514
[TBL] [Abstract][Full Text] [Related]
33. Impact of primary tumor resection in the management of metastatic well-differentiated neuroendocrine tumors of the small bowel and pancreas.
Russo A; DiPeri T; Dumitra T; Tseng J; Pletcher E; Justo M; Chen C; Nissen N; Amersi F; Gong J; Hendifar A; Gangi A
J Neuroendocrinol; 2024 May; ():e13399. PubMed ID: 38760997
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Effect of Performance Status on Outcomes of Patients with Colorectal Cancer Receiving First-Line Chemotherapy: A Meta-analysis.
Colloca GA; Venturino A
J Gastrointest Cancer; 2024 Mar; 55(1):418-426. PubMed ID: 37966630
[TBL] [Abstract][Full Text] [Related]
35. Application Evaluation of Fluorouracil Intraperitoneal Perfusion Chemotherapy in Combination with Intravenous Chemotherapy in Patients after Radical Resection of Colorectal Cancer.
Wang W
Ann Ital Chir; 2024; 95(1):98-104. PubMed ID: 38469610
[TBL] [Abstract][Full Text] [Related]
36. Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study.
Rodríguez-Lescure Á; Gallego J; Garcia-Alfonso P; Massuti B; Márquez R; Calvo L; Sánchez-Rovira P; Antón A; Chacón JI; Ciruelos E; Ponce JJ; Santaballa A; Valladares-Ayerbes M; Dueñas MR; Alonso V; Aparicio J; Encinas S; Robles L; Escudero MJ; Caballero R; Bezares S; de la Haba-Rodriguez J
Clin Transl Oncol; 2024 Apr; ():. PubMed ID: 38578537
[TBL] [Abstract][Full Text] [Related]
37. Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review.
de Mestier L; Manceau G; Neuzillet C; Bachet JB; Spano JP; Kianmanesh R; Vaillant JC; Bouché O; Hannoun L; Karoui M
World J Gastrointest Oncol; 2014 Jun; 6(6):156-69. PubMed ID: 24936226
[TBL] [Abstract][Full Text] [Related]
38. Bevacizumab-associated intestinal perforation and perioperative complications in patients receiving bevacizumab.
Yoshimoto T; Yoshikawa K; Higashijima J; Miyatani T; Tokunaga T; Nishi M; Takasu C; Kashihara H; Takehara Y; Shimada M
Ann Gastroenterol Surg; 2020 Mar; 4(2):151-155. PubMed ID: 32258980
[TBL] [Abstract][Full Text] [Related]
39. The Real-Life Impact of mFOLFIRI-Based Chemotherapies on Elderly Patients-Should We Let It or Leave It?
Pécsi B; Mangel LC
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958320
[TBL] [Abstract][Full Text] [Related]
40. Does response rate of chemotherapy with molecular target agents correlate with the conversion rate and survival in patients with unresectable colorectal liver metastases?: A systematic review.
Okuno M; Hatano E; Nishino H; Seo S; Taura K; Uemoto S
Eur J Surg Oncol; 2017 Jun; 43(6):1003-1012. PubMed ID: 27624917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
